The commercialisation of osteoarthritis treatment ZILOSUL® has hit a hiccup in the United States with the US Food and Drug…
While Americans battle to manage an array of health concerns sweeping the elderly, hearing loss may not be one of…
Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted…
Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from…
Medical imaging and research company Resonance Health (ASX: RHT) continues to advance a new artificial intelligence solution for automated alerts…
Pharmaceuticals developer Acrux (ASX: ACR) is set to expedite commercialisation of its generic topical products in the United States via…